- Home
- MEG vs ARCT Comparison
MEG vs ARCT Comparison
Compare MEG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEG
- ARCT
- Stock Information
- Founded
- MEG 2012
- ARCT 2013
- Country
- MEG United States
- ARCT United States
- Employees
- MEG N/A
- ARCT N/A
- Industry
- MEG Professional Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MEG Consumer Discretionary
- ARCT Health Care
- Exchange
- MEG Nasdaq
- ARCT Nasdaq
- Market Cap
- MEG 764.0M
- ARCT 298.3M
- IPO Year
- MEG 2020
- ARCT N/A
- Fundamental
- Price
- MEG $22.31
- ARCT $13.78
- Analyst Decision
- MEG Buy
- ARCT Strong Buy
- Analyst Count
- MEG 5
- ARCT 8
- Target Price
- MEG $31.80
- ARCT $52.83
- AVG Volume (30 Days)
- MEG 417.1K
- ARCT 484.1K
- Earning Date
- MEG 08-05-2025
- ARCT 08-04-2025
- Dividend Yield
- MEG N/A
- ARCT N/A
- EPS Growth
- MEG N/A
- ARCT N/A
- EPS
- MEG N/A
- ARCT N/A
- Revenue
- MEG $718,904,000.00
- ARCT $143,680,000.00
- Revenue This Year
- MEG $10.49
- ARCT N/A
- Revenue Next Year
- MEG $7.06
- ARCT $34.79
- P/E Ratio
- MEG N/A
- ARCT N/A
- Revenue Growth
- MEG 10.92
- ARCT 15.38
- 52 Week Low
- MEG $10.51
- ARCT $8.04
- 52 Week High
- MEG $41.35
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- MEG 57.99
- ARCT 58.14
- Support Level
- MEG $21.52
- ARCT $12.65
- Resistance Level
- MEG $22.53
- ARCT $14.09
- Average True Range (ATR)
- MEG 1.03
- ARCT 0.94
- MACD
- MEG -0.19
- ARCT 0.05
- Stochastic Oscillator
- MEG 51.71
- ARCT 64.60
About MEG Montrose Environmental Group Inc.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.